Correlation Between Dupont De and Finch Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dupont De and Finch Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Finch Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and Finch Therapeutics Group, you can compare the effects of market volatilities on Dupont De and Finch Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Finch Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Finch Therapeutics.

Diversification Opportunities for Dupont De and Finch Therapeutics

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Dupont and Finch is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Finch Therapeutics Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Finch Therapeutics and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Finch Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Finch Therapeutics has no effect on the direction of Dupont De i.e., Dupont De and Finch Therapeutics go up and down completely randomly.

Pair Corralation between Dupont De and Finch Therapeutics

Allowing for the 90-day total investment horizon Dupont De Nemours is expected to generate 0.23 times more return on investment than Finch Therapeutics. However, Dupont De Nemours is 4.29 times less risky than Finch Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Finch Therapeutics Group is currently generating about -0.08 per unit of risk. If you would invest  6,802  in Dupont De Nemours on August 26, 2024 and sell it today you would earn a total of  1,530  from holding Dupont De Nemours or generate 22.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy31.99%
ValuesDaily Returns

Dupont De Nemours  vs.  Finch Therapeutics Group

 Performance 
       Timeline  
Dupont De Nemours 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Dupont De Nemours are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Dupont De is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
Finch Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Finch Therapeutics Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental indicators, Finch Therapeutics is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

Dupont De and Finch Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dupont De and Finch Therapeutics

The main advantage of trading using opposite Dupont De and Finch Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Finch Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Finch Therapeutics will offset losses from the drop in Finch Therapeutics' long position.
The idea behind Dupont De Nemours and Finch Therapeutics Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity